{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:16:32Z","timestamp":1773674192275,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Natural Science Foundation of Jiangsu Province (CN)","award":["BK20151333"],"award-info":[{"award-number":["BK20151333"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81672999"],"award-info":[{"award-number":["81672999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Social Development Fund of Zhenjiang City","award":["SH2013041"],"award-info":[{"award-number":["SH2013041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0852-z","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T02:40:55Z","timestamp":1507084855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recombinant Newcastle disease virus rL-RVG enhances the apoptosis and inhibits the migration of A549 lung adenocarcinoma cells via regulating alpha 7 nicotinic acetylcholine receptors in vitro"],"prefix":"10.1186","volume":"14","author":[{"given":"Yulan","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Hang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"852_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"852_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12253-012-9548-2","volume":"18","author":"M Zeyaullah","year":"2012","unstructured":"Zeyaullah M, Patro M, Ahmad I, Ibraheem K, Sultan P, Nehal M, Ali A. Oncolytic viruses in the treatment of cancer: a review of current strategies. Pathol Oncol Res. 2012;18:771\u201381.","journal-title":"Pathol Oncol Res"},{"key":"852_CR3","first-page":"e1117744","volume":"5","author":"J Pol","year":"2016","unstructured":"Pol J, Buqu\u00e9 A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J7, Limacher JM, Preville X, Saut\u00e8s-Fridman C, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch\u2014Oncolytic viruses and cancer therapy. Oncoimmunology. 2016;5:e1117744.","journal-title":"Oncoimmunology"},{"key":"852_CR4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","volume":"84","author":"JM DiNapoli","year":"2010","unstructured":"DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol. 2010;84:1489\u2013503.","journal-title":"J Virol"},{"key":"852_CR5","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.0703584104","volume":"104","author":"JM DiNapoli","year":"2007","unstructured":"DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A. 2007;104:9788\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"852_CR6","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.79.21.13275-13284.2005","volume":"79","author":"A Bukreyev","year":"2005","unstructured":"Bukreyev A, Huang Z, Yang L, Elankumaran S, St. Claire M, Murphy BR, Samal SK, Collins PL. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol. 2005;79:13275\u201384.","journal-title":"J Virol"},{"key":"852_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3892\/mmr.2014.2657","volume":"11","author":"Y Yan","year":"2015","unstructured":"Yan Y, Liang B, Zhang J, Liu Y, Bu X. Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro. Mol Med Rep. 2015;11:317\u201326.","journal-title":"Mol Med Rep"},{"key":"852_CR8","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1128\/JVI.00519-11","volume":"85","author":"J Ge","year":"2011","unstructured":"Ge J, Wang X, Tao L, Wen Z, Feng N, Yang S, Xia X, Yang C, Chen H, Bu Z. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. J Virol. 2011;85:8241\u201352.","journal-title":"J Virol"},{"key":"852_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","volume":"74","author":"C Gotti","year":"2004","unstructured":"Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363\u201396.","journal-title":"Prog Neurobiol"},{"key":"852_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1568011043352687","volume":"4","author":"S Trombino","year":"2004","unstructured":"Trombino S, Bisio A, Catassi A, Cesario A, Falugi C, Russo P. Role of the non-neuronal human cholinergic system in lung cancer and mesothelioma: possibility of new therapeutic strategies. Curr Med Chem Anti Cancer Agents. 2004;4:535\u201342.","journal-title":"Curr Med Chem Anti Cancer Agents"},{"key":"852_CR11","unstructured":"World Health Organization, & World Health Organization. Cancer fact sheet. 2011.Available online: http:\/\/www. who. International. 2015\/mediacentre\/factsheets\/fs297\/en\/. (Accessed 1 Mar 2015)."},{"key":"852_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-5-27","volume":"5","author":"DL Carlisle","year":"2004","unstructured":"Carlisle DL, Hopkins TM, Gaither-Davis A, Silhanek MJ, Luketich JD, Christie NA, et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res. 2004;5:27.","journal-title":"Respir Res"},{"key":"852_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virusres.2005.11.009","volume":"120","author":"A Czegl\u00e9di","year":"2006","unstructured":"Czegl\u00e9di A, Ujv\u00e1ri D, Somogyi E, Wehmann E, Werner O, Lomniczi B. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res. 2006;120:36\u201348.","journal-title":"Virus Res"},{"key":"852_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10719-006-5433-0","volume":"23","author":"E Villar","year":"2006","unstructured":"Villar E, Barroso IM. Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J. 2006;23:5\u201317.","journal-title":"Glycoconj J"},{"key":"852_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sbi.2007.08.016","volume":"17","author":"RA Lamb","year":"2007","unstructured":"Lamb RA, Jardetzky TS. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol. 2007;17:427\u201336.","journal-title":"Curr Opin Struct Biol"},{"key":"852_CR16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1517\/14712598.2015.1088000","volume":"15","author":"V Schirrmacher","year":"2015","unstructured":"Schirrmacher V. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance. Expert Opin Biol Ther. 2015;15:1757\u201371.","journal-title":"Expert Opin Biol Ther"},{"key":"852_CR17","first-page":"386470","volume":"2014","author":"JM Abdullah","year":"2014","unstructured":"Abdullah JM, Mustafa Z, Ideris A. Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme. Biomed Res Int. 2014;2014:386470.","journal-title":"Biomed Res Int"},{"key":"852_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virusres.2015.07.001","volume":"209","author":"S Cuadrado-Castano","year":"2015","unstructured":"Cuadrado-Castano S, Sanchez-Aparicio MT, Garc\u00eda-Sastre A, Villar E. The therapeutic effect of death: Newcastle disease virus and its antitumor potential. Virus Res. 2015;209:56\u201366.","journal-title":"Virus Res"},{"key":"852_CR19","first-page":"3612","volume":"5","author":"L Hu","year":"2015","unstructured":"Hu L, Sun S, Wang T, Li Y, Jiang K, Lin G, Ma Y, Barr MP, Song F, Zhang G, Meng S. Oncolytic Newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy. Am J Cancer Res. 2015;5:3612\u201323.","journal-title":"Am J Cancer Res"},{"key":"852_CR20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0161-5890(88)90125-3","volume":"25","author":"L Bracci","year":"1988","unstructured":"Bracci L, Antoni G, Cusi MG, Lozzi L, Niccolai N, Petreni S, Rustici M, Santucci A, Soldani P, Valensin PE. Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor. Mol Immunol. 1988;25:881\u20138.","journal-title":"Mol Immunol"},{"key":"852_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01310756","volume":"114","author":"P Neri","year":"1990","unstructured":"Neri P, Bracci L, Rustici M, Santucci A. Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Arch Virol. 1990;114:265\u20139.","journal-title":"Arch Virol"},{"key":"852_CR22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/138945012800398883","volume":"13","author":"HM Schuller","year":"2012","unstructured":"Schuller HM. Regulatory role of the \u03b17nAChR in cancer. Curr Drug Targets. 2012;13:680\u20137.","journal-title":"Curr Drug Targets"},{"key":"852_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cncr.28423","volume":"120","author":"DM Moreira","year":"2014","unstructured":"Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P, Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH database. Cancer. 2014;120:197\u2013204.","journal-title":"Cancer"},{"key":"852_CR24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1055-9965.EPI-04-0652","volume":"14","author":"PA Dennis","year":"2005","unstructured":"Dennis PA, Van Waes C, Gutkind JS, Kellar KJ, Vinson C, Mukhin AG, Spitz MR, Bailey-Wilson JE, Yeh GC, Anderson LM, Wiest JS. The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomark Prev. 2005;14:764\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"852_CR25","doi-asserted-by":"crossref","first-page":"e7524","DOI":"10.1371\/journal.pone.0007524","volume":"4","author":"R Davis","year":"2009","unstructured":"Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, Chellappan S. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 2009;4:e7524.","journal-title":"PLoS One"},{"key":"852_CR26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jss.2015.10.046","volume":"201","author":"Y He","year":"2016","unstructured":"He Y, Ye ZQ, Li X, Zhu GS, Liu Y, Yao WF, Luo GJ. Alpha7 nicotinic acetylcholine receptor activation attenuated intestine-derived acute lung injury. J Surg Res. 2016;201:258\u201365.","journal-title":"J Surg Res"},{"key":"852_CR27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bcp.2013.06.031","volume":"86","author":"JW Young","year":"2013","unstructured":"Young JW, Geyer MA. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochem Pharmacol. 2013;86:1122\u201332.","journal-title":"Biochem Pharmacol"},{"key":"852_CR28","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-10-2434","volume":"17","author":"CH Wu","year":"2011","unstructured":"Wu CH, Lee CH, Ho YS. Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin Cancer Res. 2011;17:3533\u201341.","journal-title":"Clin Cancer Res"},{"key":"852_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrc2590","volume":"9","author":"HM Schuller","year":"2009","unstructured":"Schuller HM. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer. 2009;9:195\u2013205.","journal-title":"Nat Rev Cancer"},{"key":"852_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ijc.23894","volume":"124","author":"P Dasgupta","year":"2009","unstructured":"Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, Banerjee S, Carless M, Kim E, Coppola D, Haura E, Chellappan S. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124:36\u201345.","journal-title":"Int J Cancer"},{"key":"852_CR31","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"852_CR32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265\u201373.","journal-title":"Nat Rev Cancer"},{"key":"852_CR33","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1128\/MCB.01311-10","volume":"31","author":"S Pillai","year":"2011","unstructured":"Pillai S, Rizwani W, Li X, Rawal B, Nair S, Schell MJ, Bepler G, Haura E, Coppola D, Chellappan S. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol Cell Biol. 2011;31:3052\u201367.","journal-title":"Mol Cell Biol"},{"key":"852_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pharmthera.2008.10.007","volume":"121","author":"RD Egleton","year":"2009","unstructured":"Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther. 2009;121:205\u201323.","journal-title":"Pharmacol Ther"},{"key":"852_CR35","doi-asserted-by":"crossref","first-page":"456743","DOI":"10.1155\/2011\/456743","volume":"2011","author":"S Singh","year":"2011","unstructured":"Singh S, Pillai S, Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011;2011:456743.","journal-title":"J Oncol"},{"key":"852_CR36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/138945012800398847","volume":"13","author":"S Pillai","year":"2012","unstructured":"Pillai S, Chellappan S. \u03b17 nicotinic acetylcholine receptor subunit in angiogenesis and epithelial to mesenchymal transition. Curr Drug Targets. 2012;13:671\u20139.","journal-title":"Curr Drug Targets"},{"key":"852_CR37","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/md11072574","volume":"11","author":"A Zovko","year":"2013","unstructured":"Zovko A, Viktorsson K, Lewensohn R, Kolo\u0161a K, Filipi\u010d M, Xing H, Kem WR, Paleari L, Turk T. APS8, a polymeric alkylpyridinium salt blocks \u03b17 nAChR and induces apoptosis in non-small cell lung carcinoma. Mar Drugs. 2013;11:2574\u201394.","journal-title":"Mar Drugs"},{"key":"852_CR38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1158\/1541-7786.MCR-13-0541","volume":"12","author":"C Schaal","year":"2014","unstructured":"Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014;12:14\u201323.","journal-title":"Mol Cancer Res"},{"issue":"1 Suppl","key":"852_CR39","first-page":"699.3","volume":"30","author":"Z Robateau","year":"2016","unstructured":"Robateau Z, Brown KC, Creel RG, Chen YC, Grover LM, Mangiarua EI, et al. Anti-angiogenic activity of nicotinic receptor antagonists in lung cancer. FASEB J. 2016;30(1 Suppl):699.3.","journal-title":"FASEB J"},{"key":"852_CR40","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.lfs.2007.01.013","volume":"80","author":"J Arredondo","year":"2007","unstructured":"Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: alterations of the NF-kappaB expression and activity downstream of alpha7 nicotinic receptor in oral keratinocytes. Life Sci. 2007;80:2191\u20134.","journal-title":"Life Sci"},{"key":"852_CR41","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1096\/fj.06-6191com","volume":"20","author":"J Arredondo","year":"2006","unstructured":"Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: cooperation of the Ras\/Raf-1\/MEK1\/ERK and JAK-2\/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J. 2006;20:2093\u2013101.","journal-title":"FASEB J"},{"key":"852_CR42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/ol.2015.3930","volume":"11","author":"R Yoneyama","year":"2016","unstructured":"Yoneyama R, Aoshiba K, Furukawa K, Saito M, Kataba H, Nakamura H, Ikeda N. Nicotine enhances hepatocyte growth factor-mediated lung cancer cell migration by activating the \u03b17 nicotine acetylcholine receptor and phosphoinositide kinase-3-dependent pathway. Oncol Lett. 2016;11:673\u20137.","journal-title":"Oncol Lett"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0852-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T02:22:16Z","timestamp":1570155736000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0852-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0852-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]},"article-number":"190"}}